Antipsychotics for BPSD: An audit of prescribing practice in a specialist psychiatric inpatient unit

International Psychogeriatrics

Volumn 20, Issue 4, 2008, Pages 790-799

  Haw, Camilla ^a   Stubbs, Jean ^a   Yorston, Graeme ^a  

^a ST ANDREW S HOSPITAL   (United Kingdom)

Author keywords

Aggression; Atypical antipsychotics; Behavioral and psychological symptoms of dementia; Dementia; Guidelines; Off label

Indexed keywords

BENZODIAZEPINE; NEUROLEPTIC AGENT;

ADULT; AGGRESSION; AGITATION; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; CONSULTATION; CONTROLLED STUDY; DEMENTIA; DISEASE SEVERITY; DOCUMENTATION; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL SPECIALIST; MENTAL PATIENT; MORTALITY; OFF LABEL DRUG USE; PATIENT REFERRAL; PRACTICE GUIDELINE; PRESCRIPTION; PSYCHIATRIST; RISK FACTOR; STANDARD; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; AGGRESSION; ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; CLINICAL AUDIT; COMORBIDITY; DEMENTIA; DRUG UTILIZATION; ENGLAND; FEMALE; GUIDELINE ADHERENCE; HOSPITALS, PSYCHIATRIC; HUMANS; MALE; MIDDLE AGED; PRESCRIPTIONS, DRUG; PSYCHOMOTOR AGITATION; SOCIAL BEHAVIOR DISORDERS;

EID: 43949143918     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610208006819     Document Type: Article

References (19)

1. Alanen, H. M., Finne-Soveri, H., Noro, A. and Leinonen, E. (2006). Use of antipsychotic medications among elderly residents in long-term institutional care: a three-year follow-up. International Journal of Geriatric Psychiatry, 21, 288-295.
2. Ballard, C., Waite, J. and Birks, J. (2006) Atypical antipsychotics for aggression and psychosis in Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD003476. DOI: 10. 1002/14651858. CD003476.pub2.
3. Bianchetti, A., Trabucchi, M. and Cipriani, G. (2003). Aggressive behavior associated with donepezil treatment: a case report. International Journal of Geriatric Psychiatry, 18, 657-658.
4. Bouman, W. P. and Pinner, G. (1998). Violent behavior-associated with donepezil. American Journal of Psychiatry, 155, 1626-1627.
5. Duff, G. (2004). Atypical antipsychotic drugs and stroke: message from Professor Gordon Duff, Chairman, Committee on Safety of Medicines. (CEM/CMO/2004/1) http://www.info.doh.gov.uk/doh/embroadcast.nsf/vwDiscussionAll/ 3D8DBB48B26FF90280256E520045977A (last accessed 8 January 2008).
6. FDA Public Health Advisory (2005). Deaths with antipsychotics in elderly patients with behavioral disturbances. http://www.fda.gov/cder/drug/ advisory/antipsychotics.htm (last accessed 8 January 2008).
7. Gill, S. S. et al. (2005). Atypical antipsychotic drugs and risk of ischaemic stroke: population-based retrospective cohort study. BMJ, 330, 445-450.
8. Greve, M. and O'Connor, D. (2005). A survey of Australian and New Zealand old age psychiatrists' preferred medications to treat behavioral and psychological symptoms of dementia (BPSD). International Psychogeriatrics, 17, 195-205.
9. Hagen, B., Esther, C. A., Ikuta, R., Williams, R. J., Le Navenec, C. L. and Aho, M. (2005). Antipsychotic drug use in Canadian long-term care facilities: prevalence, and patterns following resident relocation. International Psychogeriatrics, 17, 179-193.
10. Lyketsos, C. G. et al. (2006). Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. American Journal of Geriatric Psychiatry, 14, 561-572.
11. National Collaborating Centre for Mental Health (2007). Dementia: a NICE-SCIE Guideline on supporting people with dementia and their carers in health and social care. National Clinical Practice Guideline no. 42. http://www.guidance.nice.org.uk/cg42 (last accessed 8 January 2008).
12. Royal College of Psychiatrists (2005). Atypical antipsychotics and behavioural and psychiatric symptoms of dementia. http//www.rcpsych.ac.uk/PDF/ BPSD.pdf. (last accessed 25 August 2007).
13. Schneider, L. S. et al. (2006). Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New England Journal of Medicine, 355, 1525-1538.
14. Snowdon, J., Day, S. and Baker, W. (2005). Why and how antipsychotic drugs are used in 40 Sydney nursing homes. International Journal of Geriatric Psychiatry, 20, 1146-1152.
15. Soyinka, A. and Lawley, D. (2007). Antipsychotic prescribing for behavioural and psychological symptoms of dementia. Psychiatric Bulletin, 31, 176-178.
16. SPSS Inc. (2006). SPSS Base 14.0 User's Guide. New Jersey: Prentice Hall.
17. Trifirò, G., Verhamme, K. M. C., Ziere, G., Caputi, A. P., Stricker, B. H. Ch. and Sturkenboom, M. C. J. M. (2007). All-cause mortality associated with atypical and typical antipsychotics in demented outpatients. Pharmacoepidemiology and Drug Safety, 16, 538-544.
18. World Health Organization (1992). The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization.
19. Yorston, G. and Pinney, A. (2000). Chlorpromazine equivalents and percentage of British National Formulary maximum recommended dose in patients receiving high-dose antipsychotics. Psychiatric Bulletin, 24, 130-132.